Abstract:BackgroundDrug-target interaction (DTI) is a vital drug design strategy that plays a significant role in many processes of complex diseases and cellular events. In the face of challenges such as extensive protein data and experimental costs, it is suggested to apply bioinformatics approaches to exploit potential interactions to design new targeted medications. Different data and interaction types bring difficulties to study involving incompatible and heterology formats. The analysis of drug-target interactions in a comprehensive and unified model is a significant challenge.MethodHere, we propose a general method for predicting interactions between small-molecule drugs and protein targets, Large-scale Drug target Screening Convolutional Neural Network (LDS-CNN), which used unified encoding to achieve the calculation of the different data formats in an integrated model to realize feature abstraction and potential object prediction.ResultOn 898,412 interaction data involving 1683 small-molecule compounds and 14,350 human proteins from 8.8 billion records, the proposed method achieved an area under the curve (AUC) of 0.96, an area under the precision-recall curve (AUPRC) of 0.95, and an accuracy of 90.13%. The experimental results illustrated that the proposed method attained high accuracy on the test set, indicating its high predictive ability in drug-target interaction prediction. LDS-CNN is effective for the prediction of large-scale datasets and datasets composed of data with different formats.ConclusionIn this study, we propose a DTI prediction method to solve the problems of unified encoding of large-scale data in multiple formats. It provides a feasible way to efficiently abstract the features among different types of drug-related data, thus reducing experimental costs and time consumption. The proposed method can be used to identify potential drug targets and candidates for the treatment of complex diseases. This work provides a reference for DTI to process large-scale data and different formats with deep learning methods and provides certain suggestions for future research.

CNN-Siam: multimodal siamese CNN-based deep learning approach for drug‒drug interaction prediction

AttentionDDI: Siamese attention-based deep learning method for drug–drug interaction predictions

CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks

Multimodal CNN-DDI: using multimodal CNN for drug to drug interaction associated events

Deep learning for drug‐drug interaction prediction: A comprehensive review

CNN-DDI - A novel deep learning method for predicting drug-drug interactions.

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

A Novel Deep Learning Model for Drug-drug Interactions

Beyond Textual Data: Predicting Drug-Drug Interactions from Molecular Structure Images using Siamese Neural Networks

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

MDNN: A Multimodal Deep Neural Network for Predicting Drug-Drug Interaction Events

TP-DDI: A Two-Pathway Deep Neural Network for Drug–Drug Interaction Prediction

Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction

Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction

DSN-DDI: an accurate and generalized framework for drug–drug interaction prediction by dual-view representation learning

Multi-View Substructure Learning for Drug-Drug Interaction Prediction

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes

Deep Convolution Neural Networks for Drug-Drug Interaction Extraction

SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug–drug interaction prediction